The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses.
about
Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleedingProton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingProton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingHigh-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysisAntioxidant Properties and Gastroprotective Effects of 2-(Ethylthio)Benzohydrazones on Ethanol-Induced Acute Gastric Mucosal Lesions in RatsA randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding.Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleedingA head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots.High Dose versus Low Dose Intravenous Pantoprazole in Bleeding Peptic Ulcer: A Randomized Clinical TrialConsensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance.Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhageTiming of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review.Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits.A real world report on intravenous high-dose and non-high-dose proton-pump inhibitors therapy in patients with endoscopically treated high-risk peptic ulcer bleeding.Current management of peptic ulcer bleeding.Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion.Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.Predictors of early rebleeding after endoscopic therapy in patients with nonvariceal upper gastrointestinal bleeding secondary to high-risk lesions.Efficacy Comparison of Divided and Infusion Intravenous Pantoprazole Methods after Endoscopic Therapy in Patients with Acute Gastrointestinal Bleeding.Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.Intravenous albumin shortens the duration of hospitalization for patients with hypoalbuminemia and bleeding peptic ulcers: a pilot study.Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding
P2860
Q24201985-B5167FC2-25BD-4CD5-8158-057C6E2781D8Q24234193-68832FEE-D3F8-4B35-9EA7-87FEA528BE14Q24244325-4ABE6095-087A-447F-A367-622AEE329E65Q24605656-533D0DD7-E535-4A65-81C7-C7E3D6C65431Q28550095-E4D0FF67-DA1B-436A-A278-E8ECBCC3DC85Q33692802-55B798AD-C452-4B18-8163-7DF28926C294Q33848591-E0A8AD87-E2D8-4793-8127-9BBC51F874D6Q33866733-3338DAD1-2C27-41F5-93DB-0BDE68BE6E3FQ33993009-9D2C2F61-A9CD-4E31-8402-CAD8774A027DQ34100357-127F5357-3F36-434A-A500-4F07BEDFF07AQ34210779-24F9DCFB-3441-4766-B971-A0B6E35C79D4Q34297907-B934416E-2B6A-4D52-A127-40BDA8978206Q34524605-D0F6C08D-C4B1-4D0F-82CC-C68051075E6BQ34735634-3529F3F1-E453-4C23-B893-F7DE48E08E50Q36111706-4208D344-2D2B-4E3A-8868-77DDC2826BB5Q36362419-490D8E18-E01A-41AC-AD13-BB456BBE9D27Q36703259-6DC89DC5-56EB-4597-9D93-DF3A98D1042AQ37173955-80ED0D07-AD00-4067-A180-6B68A37369BBQ37640614-0DB4B47F-4E5E-4424-B2DA-7F2C6FE195D6Q42010277-897FA025-59E0-4274-8E19-20F2A26D9492Q44086757-ED9ADCD2-4F44-4A5D-8175-8699ACB1BDE7Q47807972-C7390F62-CF67-48A9-A727-6800A90D2590Q56777216-234457E9-1FB7-4776-8FD9-4D8A3E963B04
P2860
The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The efficacy of high- and low- ...... ulcers and comorbid illnesses.
@en
The efficacy of high- and low- ...... ulcers and comorbid illnesses.
@nl
type
label
The efficacy of high- and low- ...... ulcers and comorbid illnesses.
@en
The efficacy of high- and low- ...... ulcers and comorbid illnesses.
@nl
prefLabel
The efficacy of high- and low- ...... ulcers and comorbid illnesses.
@en
The efficacy of high- and low- ...... ulcers and comorbid illnesses.
@nl
P2093
P1476
The efficacy of high- and low- ...... ulcers and comorbid illnesses.
@en
P2093
Ai-Wen Kao
Bor-Shyang Sheu
Chiao-Hsiung Chuang
Hsiu-Chi Cheng
P2888
P304
P356
10.1007/S10620-005-2759-6
P577
2005-07-01T00:00:00Z